Larvol Delta - ARTEMIDE01-A-Study-of-AZD2936-AntiTIGITAntiPD1-Bispecific-Antibody-in-Participants-With-Advanced-or-Metastatic-NSCLC

rilvegostomig (AZD2936) - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT04995523

Mar 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next